Global Antibody-drug Conjugates Market Insights, Forecast to 2026

Global Antibody-drug Conjugates Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antibody-drug Conjugates Product Introduction
1.2 Market Segments
1.3 Key Antibody-drug Conjugates Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by Application
1.5.1 Global Antibody-drug Conjugates Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Coronavirus Disease 2019 (Covid-19): Antibody-drug Conjugates Industry Impact
1.6.1 How the Covid-19 is Affecting the Antibody-drug Conjugates Industry
1.6.1.1 Antibody-drug Conjugates Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antibody-drug Conjugates Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antibody-drug Conjugates Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Antibody-drug Conjugates Market Size Estimates and Forecasts
2.1.1 Global Antibody-drug Conjugates Revenue 2015-2026
2.1.2 Global Antibody-drug Conjugates Sales 2015-2026
2.2 Antibody-drug Conjugates Market Size by Region: 2020 Versus 2026
2.2.1 Global Antibody-drug Conjugates Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibody-drug Conjugates Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibody-drug Conjugates Competitor Landscape by Players
3.1 Antibody-drug Conjugates Sales by Manufacturers
3.1.1 Antibody-drug Conjugates Sales by Manufacturers (2015-2020)
3.1.2 Antibody-drug Conjugates Sales Market Share by Manufacturers (2015-2020)
3.2 Antibody-drug Conjugates Revenue by Manufacturers
3.2.1 Antibody-drug Conjugates Revenue by Manufacturers (2015-2020)
3.2.2 Antibody-drug Conjugates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody-drug Conjugates Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Revenue in 2019
3.2.5 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibody-drug Conjugates Price by Manufacturers
3.4 Antibody-drug Conjugates Manufacturing Base Distribution, Product Types
3.4.1 Antibody-drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody-drug Conjugates Product Type
3.4.3 Date of International Manufacturers Enter into Antibody-drug Conjugates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Antibody-drug Conjugates Market Size by Type (2015-2020)
4.1.1 Global Antibody-drug Conjugates Sales by Type (2015-2020)
4.1.2 Global Antibody-drug Conjugates Revenue by Type (2015-2020)
4.1.3 Antibody-drug Conjugates Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody-drug Conjugates Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody-drug Conjugates Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2021-2026)
4.2.3 Antibody-drug Conjugates Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody-drug Conjugates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Antibody-drug Conjugates Market Size by Application (2015-2020)
5.1.1 Global Antibody-drug Conjugates Sales by Application (2015-2020)
5.1.2 Global Antibody-drug Conjugates Revenue by Application (2015-2020)
5.1.3 Antibody-drug Conjugates Price by Application (2015-2020)
5.2 Antibody-drug Conjugates Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody-drug Conjugates Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody-drug Conjugates Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody-drug Conjugates Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antibody-drug Conjugates by Country
6.1.1 North America Antibody-drug Conjugates Sales by Country
6.1.2 North America Antibody-drug Conjugates Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibody-drug Conjugates Market Facts & Figures by Type
6.3 North America Antibody-drug Conjugates Market Facts & Figures by Application
7 Europe
7.1 Europe Antibody-drug Conjugates by Country
7.1.1 Europe Antibody-drug Conjugates Sales by Country
7.1.2 Europe Antibody-drug Conjugates Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody-drug Conjugates Market Facts & Figures by Type
7.3 Europe Antibody-drug Conjugates Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antibody-drug Conjugates by Region
8.1.1 Asia Pacific Antibody-drug Conjugates Sales by Region
8.1.2 Asia Pacific Antibody-drug Conjugates Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibody-drug Conjugates Market Facts & Figures by Type
8.3 Asia Pacific Antibody-drug Conjugates Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antibody-drug Conjugates by Country
9.1.1 Latin America Antibody-drug Conjugates Sales by Country
9.1.2 Latin America Antibody-drug Conjugates Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibody-drug Conjugates Market Facts & Figures by Type
9.3 Central & South America Antibody-drug Conjugates Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibody-drug Conjugates by Country
10.1.1 Middle East and Africa Antibody-drug Conjugates Sales by Country
10.1.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Type
10.3 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Application
11 Company Profiles
11.1 ImmunoGen
11.1.1 ImmunoGen Corporation Information
11.1.2 ImmunoGen Description, Business Overview and Total Revenue
11.1.3 ImmunoGen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
11.1.5 ImmunoGen Recent Development
11.2 Seattle Genetics
11.2.1 Seattle Genetics Corporation Information
11.2.2 Seattle Genetics Description, Business Overview and Total Revenue
11.2.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
11.2.5 Seattle Genetics Recent Development
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description, Business Overview and Total Revenue
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Antibody-drug Conjugates Products Offered
11.3.5 Roche Recent Development
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Description, Business Overview and Total Revenue
11.4.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Antibody-drug Conjugates Products Offered
11.4.5 Takeda Recent Development
11.1 ImmunoGen
11.1.1 ImmunoGen Corporation Information
11.1.2 ImmunoGen Description, Business Overview and Total Revenue
11.1.3 ImmunoGen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
11.1.5 ImmunoGen Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antibody-drug Conjugates Market Estimates and Projections by Region
12.1.1 Global Antibody-drug Conjugates Sales Forecast by Regions 2021-2026
12.1.2 Global Antibody-drug Conjugates Revenue Forecast by Regions 2021-2026
12.2 North America Antibody-drug Conjugates Market Size Forecast (2021-2026)
12.2.1 North America: Antibody-drug Conjugates Sales Forecast (2021-2026)
12.2.2 North America: Antibody-drug Conjugates Revenue Forecast (2021-2026)
12.2.3 North America: Antibody-drug Conjugates Market Size Forecast by Country (2021-2026)
12.3 Europe Antibody-drug Conjugates Market Size Forecast (2021-2026)
12.3.1 Europe: Antibody-drug Conjugates Sales Forecast (2021-2026)
12.3.2 Europe: Antibody-drug Conjugates Revenue Forecast (2021-2026)
12.3.3 Europe: Antibody-drug Conjugates Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibody-drug Conjugates Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibody-drug Conjugates Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibody-drug Conjugates Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibody-drug Conjugates Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibody-drug Conjugates Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibody-drug Conjugates Sales Forecast (2021-2026)
12.5.2 Latin America: Antibody-drug Conjugates Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibody-drug Conjugates Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibody-drug Conjugates Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibody-drug Conjugates Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibody-drug Conjugates Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibody-drug Conjugates Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antibody-drug Conjugates Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody-drug Conjugates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Antibody-drug Conjugates Market Segments
Table 2. Ranking of Global Top Antibody-drug Conjugates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody-drug Conjugates Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Adcetris
Table 5. Major Manufacturers of Kadcyla
Table 6. COVID-19 Impact Global Market: (Four Antibody-drug Conjugates Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Antibody-drug Conjugates Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Antibody-drug Conjugates Players to Combat Covid-19 Impact
Table 11. Global Antibody-drug Conjugates Market Size Growth Rate by Application 2020-2026 (Kg)
Table 12. Global Antibody-drug Conjugates Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 13. Global Antibody-drug Conjugates Sales by Regions 2015-2020 (Kg)
Table 14. Global Antibody-drug Conjugates Sales Market Share by Regions (2015-2020)
Table 15. Global Antibody-drug Conjugates Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Antibody-drug Conjugates Sales by Manufacturers (2015-2020) (Kg)
Table 17. Global Antibody-drug Conjugates Sales Share by Manufacturers (2015-2020)
Table 18. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2019)
Table 20. Antibody-drug Conjugates Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Antibody-drug Conjugates Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Antibody-drug Conjugates Price (2015-2020) (USD/Kg)
Table 23. Antibody-drug Conjugates Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antibody-drug Conjugates Product Type
Table 25. Date of International Manufacturers Enter into Antibody-drug Conjugates Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 28. Global Antibody-drug Conjugates Sales Share by Type (2015-2020)
Table 29. Global Antibody-drug Conjugates Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Antibody-drug Conjugates Revenue Share by Type (2015-2020)
Table 31. Antibody-drug Conjugates Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 32. Global Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 33. Global Antibody-drug Conjugates Sales Share by Application (2015-2020)
Table 34. North America Antibody-drug Conjugates Sales by Country (2015-2020) (Kg)
Table 35. North America Antibody-drug Conjugates Sales Market Share by Country (2015-2020)
Table 36. North America Antibody-drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Antibody-drug Conjugates Revenue Market Share by Country (2015-2020)
Table 38. North America Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 39. North America Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 40. North America Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 41. North America Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 42. Europe Antibody-drug Conjugates Sales by Country (2015-2020) (Kg)
Table 43. Europe Antibody-drug Conjugates Sales Market Share by Country (2015-2020)
Table 44. Europe Antibody-drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Antibody-drug Conjugates Revenue Market Share by Country (2015-2020)
Table 46. Europe Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 47. Europe Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 48. Europe Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 49. Europe Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Antibody-drug Conjugates Sales by Region (2015-2020) (Kg)
Table 51. Asia Pacific Antibody-drug Conjugates Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Antibody-drug Conjugates Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 55. Asia Pacific Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 57. Asia Pacific Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 58. Latin America Antibody-drug Conjugates Sales by Country (2015-2020) (Kg)
Table 59. Latin America Antibody-drug Conjugates Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Antibody-drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Antibody-drug Conjugates Revenue Market Share by Country (2015-2020)
Table 62. Latin America Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 63. Latin America Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 64. Latin America Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 65. Latin America Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Antibody-drug Conjugates Sales by Country (2015-2020) (Kg)
Table 67. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 71. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 73. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 74. ImmunoGen Corporation Information
Table 75. ImmunoGen Description and Major Businesses
Table 76. ImmunoGen Antibody-drug Conjugates Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. ImmunoGen Product
Table 78. ImmunoGen Recent Development
Table 79. Seattle Genetics Corporation Information
Table 80. Seattle Genetics Description and Major Businesses
Table 81. Seattle Genetics Antibody-drug Conjugates Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Seattle Genetics Product
Table 83. Seattle Genetics Recent Development
Table 84. Roche Corporation Information
Table 85. Roche Description and Major Businesses
Table 86. Roche Antibody-drug Conjugates Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Roche Product
Table 88. Roche Recent Development
Table 89. Takeda Corporation Information
Table 90. Takeda Description and Major Businesses
Table 91. Takeda Antibody-drug Conjugates Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Takeda Product
Table 93. Takeda Recent Development
Table 94. Global Antibody-drug Conjugates Sales Forecast by Regions (2021-2026) (Kg)
Table 95. Global Antibody-drug Conjugates Sales Market Share Forecast by Regions (2021-2026)
Table 96. Global Antibody-drug Conjugates Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 97. Global Antibody-drug Conjugates Revenue Market Share Forecast by Regions (2021-2026)
Table 98. North America: Antibody-drug Conjugates Sales Forecast by Country (2021-2026) (Kg)
Table 99. North America: Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Europe: Antibody-drug Conjugates Sales Forecast by Country (2021-2026) (Kg)
Table 101. Europe: Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Asia Pacific: Antibody-drug Conjugates Sales Forecast by Region (2021-2026) (Kg)
Table 103. Asia Pacific: Antibody-drug Conjugates Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Latin America: Antibody-drug Conjugates Sales Forecast by Country (2021-2026) (Kg)
Table 105. Latin America: Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Middle East and Africa: Antibody-drug Conjugates Sales Forecast by Country (2021-2026) (Kg)
Table 107. Middle East and Africa: Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Market Risks
Table 111. Main Points Interviewed from Key Antibody-drug Conjugates Players
Table 112. Antibody-drug Conjugates Customers List
Table 113. Antibody-drug Conjugates Distributors List
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Sales Market Share by Type in 2020 & 2026
Figure 3. Adcetris Product Picture
Figure 4. Kadcyla Product Picture
Figure 5. Global Antibody-drug Conjugates Sales Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Antibody-drug Conjugates Report Years Considered
Figure 9. Global Antibody-drug Conjugates Market Size 2015-2026 (US$ Million)
Figure 10. Global Antibody-drug Conjugates Sales 2015-2026 (Kg)
Figure 11. Global Antibody-drug Conjugates Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Antibody-drug Conjugates Sales Market Share by Region (2015-2020)
Figure 13. Global Antibody-drug Conjugates Sales Market Share by Region in 2019
Figure 14. Global Antibody-drug Conjugates Revenue Market Share by Region (2015-2020)
Figure 15. Global Antibody-drug Conjugates Revenue Market Share by Region in 2019
Figure 16. Global Antibody-drug Conjugates Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Antibody-drug Conjugates Revenue in 2019
Figure 18. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Figure 20. Global Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 21. Global Antibody-drug Conjugates Revenue Market Share by Type (2015-2020)
Figure 22. Global Antibody-drug Conjugates Revenue Market Share by Type in 2019
Figure 23. Global Antibody-drug Conjugates Market Share by Price Range (2015-2020)
Figure 24. Global Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Figure 25. Global Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 26. Global Antibody-drug Conjugates Revenue Market Share by Application (2015-2020)
Figure 27. Global Antibody-drug Conjugates Revenue Market Share by Application in 2019
Figure 28. North America Antibody-drug Conjugates Sales Growth Rate 2015-2020 (Kg)
Figure 29. North America Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Antibody-drug Conjugates Sales Market Share by Country in 2019
Figure 31. North America Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 32. U.S. Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 33. U.S. Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 35. Canada Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Antibody-drug Conjugates Market Share by Type in 2019
Figure 37. North America Antibody-drug Conjugates Market Share by Application in 2019
Figure 38. Europe Antibody-drug Conjugates Sales Growth Rate 2015-2020 (Kg)
Figure 39. Europe Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Antibody-drug Conjugates Sales Market Share by Country in 2019
Figure 41. Europe Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 42. Germany Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 43. Germany Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 45. France Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 47. U.K. Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 49. Italy Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 51. Russia Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Antibody-drug Conjugates Market Share by Type in 2019
Figure 53. Europe Antibody-drug Conjugates Market Share by Application in 2019
Figure 54. Asia Pacific Antibody-drug Conjugates Sales Growth Rate 2015-2020 (Kg)
Figure 55. Asia Pacific Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Antibody-drug Conjugates Sales Market Share by Region in 2019
Figure 57. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Region in 2019
Figure 58. China Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 59. China Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 61. Japan Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 63. South Korea Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 65. India Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 67. Australia Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 69. Taiwan Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 71. Indonesia Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 73. Thailand Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 75. Malaysia Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 77. Philippines Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 79. Vietnam Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Antibody-drug Conjugates Market Share by Type in 2019
Figure 81. Asia Pacific Antibody-drug Conjugates Market Share by Application in 2019
Figure 82. Latin America Antibody-drug Conjugates Sales Growth Rate 2015-2020 (Kg)
Figure 83. Latin America Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Antibody-drug Conjugates Sales Market Share by Country in 2019
Figure 85. Latin America Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 86. Mexico Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 87. Mexico Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 89. Brazil Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 91. Argentina Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Antibody-drug Conjugates Market Share by Type in 2019
Figure 93. Latin America Antibody-drug Conjugates Market Share by Application in 2019
Figure 94. Middle East and Africa Antibody-drug Conjugates Sales Growth Rate 2015-2020 (Kg)
Figure 95. Middle East and Africa Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 98. Turkey Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 99. Turkey Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 101. Saudi Arabia Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 103. UAE Antibody-drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Antibody-drug Conjugates Market Share by Type in 2019
Figure 105. Middle East and Africa Antibody-drug Conjugates Market Share by Application in 2019
Figure 106. ImmunoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. North America Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 111. North America Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 113. Europe Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 115. Asia Pacific Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 117. Latin America Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 119. Middle East and Africa Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs